Labcorp to buy Toxikon

By staff writers

November 18, 2021 -- Labcorp has entered a definitive agreement to acquire Toxikon, a contract research organization delivering best-in-class nonclinical testing services.

Once completed, the acquisition will create a strategic footprint for Labcorp to partner with pharmaceutical and biotechnology clients in the Boston area and bolster its strong nonclinical development portfolio, company representatives said.

Toxikon is based in Bedford, MA, and has annual revenues of around $40 million, Labcorp said. Toxikon maintains specialized, state-of-the-art facilities and a robust roster of pharmaceutical, biotech, and medical device clients. The facility in Bedford also has capacity for growth and will provide Labcorp with an opportunity to expand its traditional toxicology business, the company said.

The transaction is expected to close during the fourth quarter of 2021, subject to customary closing conditions and regulatory approvals. Specific terms of the transaction were not disclosed.

Labcorp reports revenue gains for Q3
Labcorp reported increased revenue but lower net earnings in its third quarter. The company has also revised upward its guidance for the rest of fiscal...
Labcorp, Pillar Biosciences team up for genomic testing
Labcorp and Pillar Biosciences have signed an agreement to offer genomic cancer testing based on Pillar's next-generation sequencing technology.
GeneCentric Therapeutics teams up with Labcorp
GeneCentric Therapeutics has formed a strategic partnership with Labcorp to develop and commercialize RNA-based gene signatures for oncology diagnostics.
Labcorp acquires women's digital health firm Ovia
Labcorp announced it has acquired digital health firm Ovia Health in a move the company said aims to improve patient experience and reduce healthcare...
Labcorp deploys new SARS-CoV-2 sequencing panel
Labcorp will start using Molecular Loop Biosciences' SARS-CoV-2 research sequencing panel to sequence thousands of complete coronavirus genomes each week...

Copyright © 2021

Last Updated ls 11/18/2021 4:31:25 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current